SABCS 2022 | The impact of the COVID-19 pandemic on the management of patients with breast cancer

Diogo Martins-Branco, MD, MSc, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, discusses the impact of the COVID-19 pandemic on the management of patients with breast cancer, including the increased use of neoadjuvant endocrine therapy in postmenopausal woman and the susceptibility of patients to developing infections. This interview took place at the San Antonio Breast Cancer Symposium (SABCS) 2022 in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.